RE:RE:Next week's trial result updateI'm looking forward to the next update. It appears to be the most promising and eventually the best treatment available as each update verifies the continued improvement in the data plus the lack of negative side effects and treatment being done on a outpatient basis.
However management needs to convey to us shareholders the status of a BTD application which was supposed to happen in the fourth quarter 2022 as they stated. This missed timeline needs to be explained in the next update.